Modelling the cost-utility of breast cancer treatment Jo Fitz-Gerald Newsletter Article 08 February 2013 Pages: 3 - 4
Surgery more cost effective for gastro-oesophageal reflux Newsletter Article 08 February 2013 Pages: 5 - 5
Economic rationale for proton pump inhibitor use in GORD Newsletter Article 08 February 2013 Pages: 6 - 6
QOL impact of didanosine vs zidovudine in HIV infection Newsletter Article 08 February 2013 Pages: 6 - 7
Use genital herpes-specific QOL measure with confidence Newsletter Article 08 February 2013 Pages: 7 - 7
Economic promotions in managed care - regulation required? Newsletter Article 08 February 2013 Pages: 7 - 7